First, Do No Harm: Marshaling Clinician Leadership to Counter the Opioid Epidemic (2017)
Chapter: References
REFERENCES
AAMC (Association of American Medical Colleges). 2017. Responding to the opioid epidemic through education, patient care, and research. AAMC News, https://news.aamc.org/for-the-media/article/medical-schools-address-opioide-pidemic/ (accessed July 8, 2017).
ADA (American Dental Association). 2017. Statement on the use of opioids in the treatment of dental pain. http://www.ada.org/en/about-the-ada/ada-positions-policies-and-statements/statement-on-opioids-dental-pain (accessed July 7, 2017).
Alpert, A., D. Powell, and R. L. Pacula. 2017. Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. National Bureau of Economic Research. http://www.nber.org/papers/w23031 (accessed June 21, 2017).
AMA (American Medical Association). 2017. End the epidemic. https://www.end-opioid-epidemic.org/ (accessed May 10, 2017).
Anderson, K. O., C. R. Green, and R. Payne. 2009. Racial and ethnic disparities in pain: Causes and consequences of unequal care. Journal of Pain 10(12):1187–1204.
Astin, J. A. 2004. Mind-body therapies for the management of pain. Clinical Journal of Pain 20(1):27–32.
Barnett, M. L., A. R. Olenski, and A. B. Jena. 2017. Opioid-prescribing patterns of emergency physicians and risk of long-term use. New England Journal of Medicine 376(7):663–673, http://www.nejm.org/doi/full/10.1056/NEJMsa1610524.
Bartels, K., L. M. Mayes, C. Dingmann, K. J. Bullard, C. J. Hopfer, and I. A. Binswanger. 2016. Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One 11(1):e0147972.
Baumblatt, J., C. Wiedeman, J. R. Dunn, W. Schaffner, L. J. Paulozzi, and T. F. Jones. 2014. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Internal Medicine 174(5):796–801. http://dx.doi.org/10.1001/jamainternmed.2013.12711.
Bruehl, S., A. V. Apkarian, J. C. Ballantyne, A. Berger, D. Borsook, W. G. Chen, J. T. Farrar, J. A. Haythornthwaite, S. D. Horn, and M. J. Iadarola. 2013. Personalized medicine and opioid analgesic prescribing for chronic pain: Opportunities and challenges. Journal of Pain 14(2):103–113.
Case, A., and A. Deaton. 2015. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences 112(49):15078–15083.
CBHSQ (Center for Behavioral Health Statistics and Quality). 2014. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS publication no. SMA 15–4927, NSDUH Series H-50. Rockville, MD: Substance Abuse and Mental Health Services Administration, https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf.
CDC (Centers for Disease Control and Prevention). 2015. CDC Wonder: About multiple cause of death, 1999–2015. https://wonder.cdc.gov/mcd-icd10.html (accessed August 29, 2017).
CDC. 2017a. National Center for Health Statistics: Mortality data. https://www.cdc.gov/nchs/nvss/deaths.htm (accessed July 20, 2017).
CDC. 2017b. Provisional counts of drug overdose deaths, as of 8/6/2017. Atlanta, GA: National Center for Health Statistics, https://www.cdc.gov/nchs/data/health_policy/monthly-drug-overdose-death-estimates.pdf (accessed September 5, 2017).
CDC. 2017c. US prescribing rate maps. https://www.cdc.gov/drugoverdose/maps/rxrate-maps.html (accessed August 29, 2017).
Chaparro, L. E., A. D. Furlan, A. Deshpande, A. Mailis-Gagnon, S. Atlas, and D. C. Turk. 2013. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database of Systemic Reviews (8):Cd004959.
Chou, R., R. Deyo, B. Devine, R. Hansen, S. Sullivan, J. G. Jarvik, I. Blazina, T. Dana, C. Bougatsos, and J. Turner. 2014. The effectiveness and risks of long-term opioid treatment of chronic pain: Evidence reports/technology assessments no. 218. Report 14-e005-ef. Rockville, MD: Agency for Healthcare Research and Quality.
Cicero, T. J., M. S. Ellis, H. L. Surratt, and S. P. Kurtz. 2014. The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry 71(7):821–826.
Compton, W. M., C. M. Jones, and G. T. Baldwin. 2016. Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine 374(2):154–163, http://www.nejm.org/doi/full/10.1056/NEJMra1508490 (June 19, 2017).
Dowell, D., T. M. Haegerich, and R. Chou. 2016. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 315(15):1624–1645.
Dunn, K. M., K. W. Saunders, C. M. Rutter, C. J. Banta-Green, J. O. Merrill, M. D. Sullivan, C. M. Weisner, M. J. Silverberg, C. I. Campbell, and B. M. Psaty and M. Von Korff. 2010. Opioid prescriptions for chronic pain and overdose — A cohort study. Annals of Internal Medicine 152(2):85–92.
DuPont, R. L. 1971. Profile of a heroin-addiction epidemic. New England Journal of Medicine 285(6):320–324.
Edlund, M. J., B. C. Martin, J. E. Russo, A. Devries, J. B. Braden, and M. D. Sullivan. 2014. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: The role of opioid prescription. Clinical Journal of Pain 30(7):557–564, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032801/ (accessed June 19, 2017).
Ehde, D. M., T. M. Dillworth, and J. A. Turner. 2014. Cognitive-behavioral therapy for individuals with chronic pain: Efficacy, innovations, and directions for research. American Psychologist 69(2):153.
Etheredge, L. M. 2007. A rapid-learning health system. Health Affairs 26(2):w107-w118.
FDA (Food and Drug Administration). 2017a. Introduction for the FDA blueprint for prescriber education for extended-release and long-acting opioid analgesics. https://www.fda.gov/downloads/drugs/drugsafety/informationbydrugclass/ucm515636.pdf (accessed July 15, 2017).
FDA. 2017b. Timeline of selected FDA activities and significant events addressing opioid misuse and abuse. https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm338566.htm (accessed June 19, 2017).
FDA. 2017c. Opioid medications. https://www.fda.gov/newsevents/newsroom/factsheets/ucm514939.htm (accessed July 5, 2017).
Florence, C. S., C. Zhou, F. Luo, and L. Xu. 2016. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care 54(10):901–906.
FSMB (Federation of State Medical Boards). 2017. Guidelines for the chronic use of opioid analgesics. Euless, TX, https://www.fsmb.org/Media/Default/PDF/Advocacy/Opioid%20Guidelines%20As%20Adopted%20April%202017_FINAL.pdf (accessed June 9, 2017).
Garland, E. L., E. G. Manusov, B. Froeliger, A. Kelly, J. M. Williams, and M. O. Howard. 2014. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: Results from an early-stage randomized controlled trial. Journal of Consulting and Clinical Psychology 82(3):448.
Gatchel, R. J., and A. Okifuji. 2006. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. Journal of Pain 7(11):779–793.
Ghandour, L., S. Martins, and H. Chilcoat. 2008. Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach. International Journal of Methods in Psychiatric Research 17(2): 89–103.
Guy, G. P. 2017. Vital signs: Changes in opioid prescribing in the United States, 2006–2015. Morbidity and Mortality Weekly Report 66(26):697–704.
Han, B., W. M. Compton, C. Blanco, E. Crane, J. Lee, and C. M. Jones. 2017. Prescription opioid use, misuse, and use disorders in US adults: 2015 national survey on drug use and health. Annals of Internal Medicine 167(5):293–301. http://dx.doi.org/10.7326/M17-0865.
Hayden, J. A., M. W. Van Tulder, and G. Tomlinson. 2005. Systematic review: Strategies for using exercise therapy to improve outcomes in chronic low back pain. Annals of Internal Medicine 142(9):776–785.
HKFF (Henry J. Kaiser Family Foundation). 2015. Opioid overdose deaths by race/ ethnicity. https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-raceethnicity/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D.
Honig, E. 2017. As opioid overdoses bleed city’s budget, councilman proposes stopping treatment. NPR, June 29, 2017, http://www.npr.org/2017/06/29/534916080/ohio-town-struggles-to-afford-life-saving-drug-for-opioid-overdoses (accessed July 10, 2017).
INCB (International Narcotics Control Board). 2016. Estimated world requirements for 2017—Statistics for 2015. https://www.incb.org/incb/en/narcotic-drugs/Technical_Reports/2016/narcotic-drugs-technical-report-2016.html (accessed July 5, 2017).
Joint Commission. 2016. Joint commission statement on pain management. https://www.jointcommission.org/joint_commission_statement_on_pain_management (accessed July 5, 2017).
Jones, C. M., L. J. Paulozzi, and K. A. Mack. 2014. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008–2011. JAMA Internal Medicine 174(5):802–803.
Jones, C. M., M. Campopiano, G. Baldwin, and E. McCance-Katz. 2015. National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health 105(8):e55-e63.
Katz, J. 2017. Drug deaths in America are rising faster than ever. The New York Times, June 5, https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html.
Keyes, K. M., M. Cerdá, J. E. Brady, J. R. Havens, and S. Galea. 2014. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health 104(2):e52-e59.
Kirson, N. Y., L. M. Scarpati, C. J. Enloe, A. P. Dincer, H. G. Birnbaum, and T. J. Mayne. 2017. The economic burden of opioid abuse: Updated findings. Journal of Managed Care and Specialty Pharmacy 23(4):427–445.
Kissin, I. 2013. Long-term opioid treatment of chronic nonmalignant pain: Unproven efficacy and neglected safety? Journal of Pain Research 6:513–529, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712997/ (accessed June 27, 2017).
Kolodny, A. 2015. The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review Public Health 36:559–574, http://www.annualreviews.org/doi/pdf/10.1146/annurev-publhealth-031914-122957 (accessed June 19, 2017).
Krebs, E., S. Noorbaloochi, M. Bair, B. DeRonne, A. Gravely, A. Jensen, and K. Kroenke. 2017. Effectiveness of opioid therapy vs. non-opioid medication therapy for chronic back and osteoarthritis pain over 12 months: A pragmatic randomized trial. Washington DC: Society for General Internal Medicine.
Larochelle, M. R., J. M. Liebschutz, F. Zhang, D. Ross-Degnan, and J. F. Wharam. 2016. Opioid prescribing after nonfatal overdose and association with repeated overdose: A cohort study. Annals of Internal Medicine 164(1):1–9.
Martell, B. A., P. G. O’Connor, R. D. Kerns, W. C. Becker, K. H. Morales, T. R. Kosten, and D. A. Fiellin. 2007. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine 146(2):116–127.
Martin, A. S. C. H. B. 2017. Characteristics of initial prescription episodes and likelihood of long-term opioid use — United States, 2006–2015. Morbidity and Mortality Weekly Report 66(10), https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6610.pdf (accessed July 28, 2017).
McNicol, E. D., A. Midbari, and E. Eisenberg. 2013. Opioids for neuropathic pain. Cochrane Database for Systematic Reviews (8).
Meier, B. 2007. In guilty plea, OxyContin maker to pay $600 million. The New York Times, May 10, http://www.nytimes.com/2007/05/10/business/11drug-web.html (accessed June 1, 2017).
Minozzi, S., L. Amato, and M. Davoli. 2013. Development of dependence following treatment with opioid analgesics for pain relief: A systematic review. Addiction 108(4):688–698.
Miró, E., M. P. Martínez, A. I. Sánchez, G. Prados, and A. Medina. 2011. When is pain related to emotional distress and daily functioning in fibromyalgia syndrome? The mediating roles of self efficacy and sleep quality. British Journal of Health Psychology 16(4):799–814.
Moore, R. A., P. J. Wiffen, S. Derry, T. Maguire, Y. M. Roy, and L. Tyrrell. 2015. Non-prescription (OTC) oral analgesics for acute pain — An overview of Cochrane reviews. Cochrane Database of Systemic Reviews (11):Cd010794.
Muhuri, P., J. Gfroerer, and C. Davies. 2013. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. SAMHSA Center for Behavioral Health Statistics and Quality Data Review, http://archive.samhsa.gov/data/2k13/DataReview/DR006/nonmedical-pain-reliever-use-2013.pdf.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2017. Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. Edited by R. J. Bonnie, M. A. Ford, and J. K. Phillips. Washington, DC: The National Academies Press.
Noble, M., J. R. Treadwell, S. J. Tregear, V. H. Coates, P. J. Wiffen, C. Akafomo, and K. M. Schoelles. 2010. Long-term opioid management for chronic noncancer pain. Cochrane Database of Systemic Reviews 1(1).
Paice, J. A., and J. H. V. Roenn. 2014. Under- or overtreatment of pain in the patient with cancer: How to achieve proper balance. Journal of Clinical Oncology 32(16):1721–1726, http://ascopubs.org/doi/abs/10.1200/JCO.2013.52.5196 (accessed June 19, 2017).
Papaleontiou, M., C. R. Henderson Jr., B. J. Turner, A. A. Moore, Y. Olkhovskaya, L. Amanfo, and M. C. Reid. 2010. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: A systematic review and meta analysis. Journal of the American Geriatrics Society 58(7):1353–1369.
Paulozzi, L. J., and Y. Xi. 2008. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiology and Drug Safety 17(10):997–1005.
Paulozzi, L. J., C. M. Jones, K. A. Mack, R. A. Rudd. 2011. Vital signs: Overdoses of prescription opioid pain relievers — United States, 1999–2008. Morbidity and Mortality Weekly Report 60(43):1487.
Portenoy, R. K., and K. M. Foley. 1986. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 25(2):171–186.
Porter, J., and H. Jick. 1980. Addiction rare in patients treated with narcotics. The New England Journal of Medicine 302(2):123.
Rapoport, A. B., and C. F. Rowley. 2017. Stretching the scope — Becoming frontline addiction-medicine providers. New England Journal of Medicine 377(8):705–707, http://www.nejm.org/doi/full/10.1056/NEJMp1706492.
Reid, M. C., D. A. Bennett, W. G. Chen, B. A. Eldadah, J. T. Farrar, B. Ferrell, R. M. Gallagher, J. T. Hanlon, K. Herr, and S. D. Horn. 2011. Improving the pharmacologic management of pain in older adults: Identifying the research gaps and methods to address them. Pain Medicine 12(9):1336–1357.
Ringwalt, C., A. W. Roberts, H. Gugelmann, and A. C. Skinner. 2015. Racial disparities across provider specialties in opioid prescriptions dispensed to
Medicaid beneficiaries with chronic noncancer pain. Pain Medicine 16(4): 633–640.
Rudd, R. A., P. Seth, F. David, and L. Scholl. 2016. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. Morbidity and Mortality Weekly Report 65(50–51):1445–1452, https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1.htm.
Saloner, B., and S. Karthikeyan. 2015. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004–2013. JAMA 314(14):1515–1517.
SAMHSA (Substance Abuse and Mental Health Services Administration). 2013. Hightlights of the 2011 drug abuse warning network (DAWN) findings on drug-related emergency department visits. SAMHSA DAWN Report, https://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127-DAWN-highlights.pdf (accessed June 28, 2017).
SAMHSA. 2017a. Buprenorphine waiver management. https://www.samhsa.gov/medication-assisted-treatment/buprenorphine-waiver-management (accessed September 15, 2017 ).
SAMHSA. 2017b. Qualify for nurse practitioners (NPs) and physician assistants (PAs) waiver. https://www.samhsa.gov/medication-assisted-treatment/qualify-nps-pas-waivers (accessed September 15, 2017).
Smith, M. T., and J. A. Haythornthwaite. 2004. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Medicine Reviews 8(2):119–132.
VA/DoD (Department of Veterans Affairs/Department of Defense). 2017. VA/DoD clinical practice guideline for opioid therapy for chronic pain. Washington, DC, https://www.healthquality.va.gov/guidelines/Pain/cot/VADoDOTCPGProviderSummary022817.pdf.
Van Middelkoop, M., S. M. Rubinstein, T. Kuijpers, A. P. Verhagen, R. Ostelo, B. W. Koes, and M. W. van Tulder. 2011. A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain. European Spine Journal 20(1):19–39.
Van Zee, A. 2009. The promotion and marketing of OxyContin: Commercial triumph, public health tragedy. American Journal of Public Health 99(2):221–227.
Volkow, N. D., and F. S. Collins. 2017. The role of science in addressing the opioid crisis. New England Journal of Medicine 377:391–394, http://www.nejm.org/doi/full/10.1056/NEJMsr1706626.
Volkow, N. D., and A. T. McLellan. 2016. Opioid abuse in chronic pain — Misconceptions and mitigation strategies. New England Journal of Medicine 374(13):1253–1263, http://www.nejm.org/doi/full/10.1056/NEJMra1507771.
Von Korff, M., A. Kolodny, R. A. Deyo, and R. Chou. 2011. Long-term opioid therapy reconsidered. Annals of Internal Medicine 155(5):325–328.
Wedell, K. 2017. Solutions sought to curb opioid epidemic. Dayton (OH) Daily News, June 2, http://www.mydaytondailynews.com/news/local/solutions-sought-curb-opioid-epidemic/BqUoBPhRlV9d5qXp7dTVtK/ (accessed July 5, 2017).
Weiss, A., A. Elixhauser, M. Barrett, C. Steiner, M. Bailey, and L. O’Malley. 2016. Opioid-related inpatient stays and emergency department visits by state, 2009–2014. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb219-Opioid-Hospital-Stays-ED-Visits-by-State.jsp (accessed September 15, 2017).
Weiss, A. J., M. L. Barrett, K. C. Heslin, and C. Stocks. 2016. Trends in emergency department visits involving mental and substance use disorders, 2006–2013. Rockville, MD: Agency for Healthcare Research and Quality, https://www.hcup-us.ahrq.gov/reports/statbriefs/sb216-Mental-Substance-Use-Disorder-ED-Visit-Trends.pdf (accessed July 11, 2017).
Weisse, C. S., K. K. Foster, and E. A. Fisher. 2005. The influence of experimenter gender and race on pain reporting: Does racial or gender concordance matter? Pain Medicine 6(1):80–87.
